Propolis-loaded/dextrose˗coated bilosomes for enhanced protection against CCl4-induced liver injury: In vitro and in vivo assessments

IF 4.9 3区 医学 Q1 PHARMACOLOGY & PHARMACY Journal of Drug Delivery Science and Technology Pub Date : 2025-05-01 Epub Date: 2025-02-26 DOI:10.1016/j.jddst.2025.106756
Reham Mokhtar Aman , Randa Ahmed Zaghloul , Noha Mohamed Saleh
{"title":"Propolis-loaded/dextrose˗coated bilosomes for enhanced protection against CCl4-induced liver injury: In vitro and in vivo assessments","authors":"Reham Mokhtar Aman ,&nbsp;Randa Ahmed Zaghloul ,&nbsp;Noha Mohamed Saleh","doi":"10.1016/j.jddst.2025.106756","DOIUrl":null,"url":null,"abstract":"<div><div>Hepatoprotection against issues like alcohol, chemicals, infections, and drugs can terminate the progression into chronic deterioration. We planned to fabricate lectin receptors-targeted bilosomes (BLs), maximizing the hepatoprotective benefits of the nature-derived honey-glue; propolis (ProE). The thin film hydration approach ensnared ProE in different BLs that were evaluated regarding encapsulation efficiency percent (EE %), vesicular diameter (D<sub>v</sub>), polydispersity index (PI), and zeta potential (ζ-potential). A selected formulation (F2) was decorated with dextrose (DEX) to create ProE-loaded/DEX-coated BLs which were thoroughly appraised concerning D<sub>v</sub>, PI, ζ-potential, morphology, opsonization, physical stability, stability in biological fluids, <em>in vitro</em> release, and ultimately <em>in vivo</em> hepatoprotective effectiveness against CCl<sub>4</sub>-induced hepatotoxicity in mice. F2 was selected as the preferred formulation based on its maximum EE% (92.70 ± 5.05 %), ζ-potential (−58.54 ± 7.73 mV), small D<sub>v</sub> (91.96 ± 5.37 nm), and acceptable PI (0.408 ± 0.06). The DEX˗coating yielded homogeneous nanosized spherical BLs (116.23 ± 11.69 nm) manifesting an avoidance of opsonization. The configuration of ProE-loaded/DEX˗coated BLs was not disrupted by storage at 4 °C. The oral administration is recommended to be on an empty stomach. ProE-loaded/DEX˗coated BLs illustrated controlled release (64.35 ± 15.36 %). Among the pretreated groups, ProE-loaded/DEX˗coated BLs could hinder the rise in the hepatic (ALT, AST, and ALP) and inflammatory (CRP) markers. In the hepatic environment, the balance of oxidative stress markers (MDA, GSH, NOx, and Nrf-2/HO-1) and p53 expression level could be recovered via the pretreatment with ProE-loaded/DEX˗coated BLs. Thus, the ProE-loaded/DEX-coated BLs should be given as much attention as a promising hepatoprotective remedy.</div></div>","PeriodicalId":15600,"journal":{"name":"Journal of Drug Delivery Science and Technology","volume":"107 ","pages":"Article 106756"},"PeriodicalIF":4.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drug Delivery Science and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1773224725001595","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Hepatoprotection against issues like alcohol, chemicals, infections, and drugs can terminate the progression into chronic deterioration. We planned to fabricate lectin receptors-targeted bilosomes (BLs), maximizing the hepatoprotective benefits of the nature-derived honey-glue; propolis (ProE). The thin film hydration approach ensnared ProE in different BLs that were evaluated regarding encapsulation efficiency percent (EE %), vesicular diameter (Dv), polydispersity index (PI), and zeta potential (ζ-potential). A selected formulation (F2) was decorated with dextrose (DEX) to create ProE-loaded/DEX-coated BLs which were thoroughly appraised concerning Dv, PI, ζ-potential, morphology, opsonization, physical stability, stability in biological fluids, in vitro release, and ultimately in vivo hepatoprotective effectiveness against CCl4-induced hepatotoxicity in mice. F2 was selected as the preferred formulation based on its maximum EE% (92.70 ± 5.05 %), ζ-potential (−58.54 ± 7.73 mV), small Dv (91.96 ± 5.37 nm), and acceptable PI (0.408 ± 0.06). The DEX˗coating yielded homogeneous nanosized spherical BLs (116.23 ± 11.69 nm) manifesting an avoidance of opsonization. The configuration of ProE-loaded/DEX˗coated BLs was not disrupted by storage at 4 °C. The oral administration is recommended to be on an empty stomach. ProE-loaded/DEX˗coated BLs illustrated controlled release (64.35 ± 15.36 %). Among the pretreated groups, ProE-loaded/DEX˗coated BLs could hinder the rise in the hepatic (ALT, AST, and ALP) and inflammatory (CRP) markers. In the hepatic environment, the balance of oxidative stress markers (MDA, GSH, NOx, and Nrf-2/HO-1) and p53 expression level could be recovered via the pretreatment with ProE-loaded/DEX˗coated BLs. Thus, the ProE-loaded/DEX-coated BLs should be given as much attention as a promising hepatoprotective remedy.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
负载蜂胶/葡萄糖的二体——增强对ccl4诱导的肝损伤的保护:体外和体内评估
保护肝脏不受酒精、化学物质、感染和药物等问题的影响,可以阻止病情发展为慢性恶化。我们计划制造凝集素受体靶向胆囊体(BLs),最大限度地发挥天然来源的蜂蜜胶的肝脏保护作用;蜂胶(证明)。薄膜水化方法捕获了不同bl中的ProE,并对其包封率(EE %)、囊泡直径(Dv)、多分散性指数(PI)和ζ电位(ζ-电位)进行了评估。将选定的配方(F2)用葡萄糖(DEX)修饰以制备proe负载/DEX包被的BLs,对其进行Dv、PI、β -电位、形态、调控、物理稳定性、生物体液稳定性、体外释放以及对ccl4诱导的小鼠肝毒性的体内保护作用等方面的全面评价。考虑到F2的最大EE%(92.70±5.05%)、ζ-电位(- 58.54±7.73 mV)、小Dv(91.96±5.37 nm)和可接受PI(0.408±0.06),选择F2为优选配方。DEX - rex涂层可获得均匀的纳米级球形BLs(116.23±11.69 nm),避免了偶声作用。在4°C条件下保存,对ProE-loaded/DEX - coated的dna结构没有影响。建议空腹口服。ProE-loaded/DEX - coated——控释(64.35±15.36%)。在预处理组中,ProE-loaded/DEX - coated的BLs可抑制肝脏(ALT、AST和ALP)和炎症(CRP)标志物的升高。在肝脏环境中,用proe -load /DEX - coated的bp进行预处理,可以恢复氧化应激标志物(MDA、GSH、NOx、nif -2/HO-1)和p53表达水平的平衡。因此,proe负载/ dex包被的BLs应该作为一种有前途的肝保护药物给予同样的重视。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.00
自引率
8.00%
发文量
879
审稿时长
94 days
期刊介绍: The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on controlled release, bioavailability and drug absorption, nanomedicines, gene delivery, tissue engineering, etc. Hot topics, related to manufacturing processes and quality control, are also welcomed.
期刊最新文献
Genotoxicity assessment of cardioprotective terbium hydroxide nanorods: A comprehensive in vitro and in vivo study Morphological, structural, and release characteristics of electrospun Eudragit S100 fibers tailored via solvent strategy and coaxial design Network pharmacology-guided repurposing of vardenafil via intranasal transfersomal in-situ hydrogel for brain-targeted neuroprotection in chemotherapy-induced cognitive dysfunction Quality-by Design amlodipine besylate-loaded transfersomal gel for transdermal application with sustained release and improved bioavailability Development of a nanocomposite floating film: Zein nanoparticles embedded in alginate/xanthan gum matrix for the gastroretentive delivery of drotaverine hydrochloride
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1